Spotlight on Interstitial Lung Disease Diagnosis and Treatment on ILD Day, Sept. 18
Nine leading patient organizations are uniting to present the fourth annual ILD Day on Wednesday, Sept. 18, to raise ...
Morningstar13d
Spotlight on Interstitial Lung Disease Diagnosis and Treatment on ILD Day, Sept. 18
including dermatomyositis and polymyositis (DM and PM), sarcoidosis and Sjögren's, may develop ILD. A specific form of ILD, namely idiopathic pulmonary fibrosis (IPF), primarily occurs in older ...
Merck Receives Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Regimens as Treatment for Patients With Two Types of Gynecologic Cancers
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...
Eagle-Tribune13d
Roivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and ...
The PH-ILD prevalence is meaningfully greater ... a potent small molecule inhibitor of TYK2 and JAK1 for the treatment of dermatomyositis and non-infectious uveitis, in addition to other clinical ...
Ten-Year Data for Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Sustained Overall Survival Benefit Versus Ipilimumab in Advanced Melanoma
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term overall survival (OS) data ...
SciELO9d
Anti MDA-5 associated rapidly progressive interstitial lung disease complicated by viral pneumonia - a fatal outcome
DM treatment is based on the long-term administration ... Anti MDA-5 DM has recently been identified as a subtype of myositis characteristically associated with RP-ILD. The clinical phenotype is ...
Frontiers11d
Poor prognostic factors for relapse of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies after combination therapy
We examined patients who experienced ILD relapse after immunosuppressive treatment. We explored the risk factors ... Japan) and a blot assay (Myositis Profile Euroline Blot Test Kit; EUROIMMUN, Lübeck ...
gastroenterologyadvisor27d
Aggressive GERD Treatment Improves Survival in Systemic Sclerosis-ILD
While gastroesophageal reflux disease (GERD) treatment does not influence the development or severity of interstitial lung disease (ILD), aggressive treatment ... of cardiopulmonary manifestations, ...